Aurora Kinase Inhibitors in Head and Neck Cancer

被引:2
|
作者
Qi, Guangying [1 ]
Liu, Jing [1 ]
Mi, Sisi [1 ]
Tsunematsu, Takaaki [2 ]
Jin, Shengjian [1 ]
Shao, Wenhua [1 ]
Liu, Tian [1 ]
Ishimaru, Naozumi [2 ]
Tang, Bo [1 ]
Kudo, Yasusei [2 ]
机构
[1] Guilin Med Univ, Affiliated Hosp, Dept Pathol & Physiopathol Hepatobiliary Surg, Guilin 541000, Peoples R China
[2] Univ Tokushima, Inst Biomed Sci, Dept Oral Mol Pathol, Grad Sch, Tokushima 7708504, Japan
基金
中国国家自然科学基金;
关键词
Aurora kinases; Mitosis; Head and neck cancer; Aurora kinase inhibitor; Tumor; Biological function; SMALL-MOLECULE INHIBITOR; ACUTE MYELOID-LEUKEMIA; CHROMOSOMAL PASSENGER PROTEIN; SPINDLE ASSEMBLY CHECKPOINT; HUMAN COLORECTAL CANCERS; SUPPRESSES TUMOR-GROWTH; CELLS IN-VITRO; SELECTIVE AURORA; B-KINASE; A KINASE;
D O I
10.2174/1568026618666180112163741
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aurora kinases are a group of serine/threonine kinases responsible for the regulation of mitosis. In recent years, with the increase in Aurora kinase-related research, the important role of Aurora kinases in tumorigenesis has been gradually recognized. Aurora kinases have been regarded as a new target for cancer therapy, resulting in the development of Aurora kinase inhibitors. The study and application of these small-molecule inhibitors, especially in combination with chemotherapy drugs, represent a new direction in cancer treatment. This paper reviews studies on Aurora kinases from recent years, including studies of their biological function, their relationship with tumor progression, and their inhibitors.
引用
收藏
页码:199 / 213
页数:15
相关论文
共 50 条
  • [41] AURORA KINASE A INHIBITION AND PACLITAXEL AS TARGETED COMBINATION THERAPY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Mazumdar, Abhijit
    Henderson, Ying C.
    El-Naggar, Adel K.
    Sen, Subrata
    Clayman, Gary L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (05): : 625 - 634
  • [42] Cancer Cell Resistance to Aurora Kinase Inhibitors: Identification of Novel Targets for Cancer Therapy
    Hrabakova, Rita
    Kollareddy, Madhu
    Tyleckova, Jirina
    Halada, Petr
    Hajduch, Marian
    Gadher, Suresh Jivan
    Kovarova, Hana
    JOURNAL OF PROTEOME RESEARCH, 2013, 12 (01) : 455 - 469
  • [43] Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
    Christopher D Scharer
    Noelani Laycock
    Adeboye O Osunkoya
    Sanjay Logani
    John F McDonald
    Benedict B Benigno
    Carlos S Moreno
    Journal of Translational Medicine, 6
  • [44] Structural basis for the design of allosteric inhibitors of the Aurora kinase A enzyme in the cancer chemotherapy
    de Souza, Valeria Barbosa
    Kawano, Daniel Fabio
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2020, 1864 (01):
  • [45] Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
    Scharer, Christopher D.
    Laycock, Noelani
    Osunkoya, Adeboye O.
    Logani, Sanjay
    McDonald, John F.
    Benigno, Benedict B.
    Moreno, Carlos S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
  • [46] Cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors and their role in head and neck cancer
    Jeannon, JP
    Wilson, JA
    CLINICAL OTOLARYNGOLOGY, 1998, 23 (05): : 420 - 424
  • [47] The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells-A Systematic Analysis
    Schoenwaelder, Nina
    Salewski, Inken
    Engel, Nadja
    Krause, Mareike
    Schneider, Bjoern
    Muller, Michael
    Riess, Christin
    Lemcke, Heiko
    Skorska, Anna
    Grosse-Thie, Christina
    Junghanss, Christian
    Maletzki, Claudia
    CANCERS, 2021, 13 (10)
  • [48] Design and synthesis of potent Aurora kinase inhibitors
    Chu, Chang-Ying
    Mohane, Coumar S.
    Hsu, John Tsu-An
    Yeh, Teng-Kuang
    Chen, Chiung-Tong
    Chao, Yu-Sheng
    Hsieh, Hsing-Pang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [49] Aurora Kinase inhibitors: Current Status and Outlook
    Bavetsias, Vassilios
    Linardopoulos, Spiros
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [50] The pharmacophore hypothesis of novel inhibitors for Aurora A kinase
    Wang Xiao-Jian
    Chen Ya-Dong
    Yang Qian
    You Qi-Dong
    CHINESE JOURNAL OF CHEMISTRY, 2007, 25 (12) : 1911 - 1918